Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
Identifieur interne : 000D27 ( Main/Exploration ); précédent : 000D26; suivant : 000D28Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
Auteurs : Christian Funck-Brentano [France] ; Joe-Elie Salem [France] ; Lee S. Nguyen [France] ; Milou-Daniel Drici [France] ; Dan M. Roden [États-Unis]Source :
- Archives of cardiovascular diseases [ 1875-2128 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Infections à coronavirus.
- Azithromycine, Betacoronavirus, Chloroquine, Humains, Hydroxychloroquine, Maladies cardiovasculaires, Pandémies, Pneumopathie virale, Torsades de pointes.
English descriptors
- KwdEn :
- MESH :
- chemical : Azithromycin, Chloroquine, Hydroxychloroquine.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Cardiovascular Diseases, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2, Torsades de Pointes.
DOI: 10.1016/j.acvd.2020.04.001
PubMed: 32331979
PubMed Central: PMC7158843
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.</title><author><name sortKey="Funck Brentano, Christian" sort="Funck Brentano, Christian" uniqKey="Funck Brentano C" first="Christian" last="Funck-Brentano">Christian Funck-Brentano</name><affiliation wicri:level="3"><nlm:affiliation>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France. Electronic address: christian.funck-brentano@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Salem, Joe Elie" sort="Salem, Joe Elie" uniqKey="Salem J" first="Joe-Elie" last="Salem">Joe-Elie Salem</name><affiliation wicri:level="3"><nlm:affiliation>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Nguyen, Lee S" sort="Nguyen, Lee S" uniqKey="Nguyen L" first="Lee S" last="Nguyen">Lee S. Nguyen</name><affiliation wicri:level="3"><nlm:affiliation>Intensive Care Medicine department, Cochin University Hospital, AP-HP Centre, 75014 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Intensive Care Medicine department, Cochin University Hospital, AP-HP Centre, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Drici, Milou Daniel" sort="Drici, Milou Daniel" uniqKey="Drici M" first="Milou-Daniel" last="Drici">Milou-Daniel Drici</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pharmacology and Toxicology, PharmacoVigilance Centre, Hôpital de Cimiez, University of Nice Côte d'Azur Medical Centre, 06003, Nice, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Pharmacology and Toxicology, PharmacoVigilance Centre, Hôpital de Cimiez, University of Nice Côte d'Azur Medical Centre, 06003, Nice</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Nice</settlement></placeName></affiliation></author><author><name sortKey="Roden, Dan M" sort="Roden, Dan M" uniqKey="Roden D" first="Dan M" last="Roden">Dan M. Roden</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN</wicri:regionArea><placeName><region type="state">Tennessee</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32331979</idno><idno type="pmid">32331979</idno><idno type="doi">10.1016/j.acvd.2020.04.001</idno><idno type="pmc">PMC7158843</idno><idno type="wicri:Area/Main/Corpus">001885</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001885</idno><idno type="wicri:Area/Main/Curation">001885</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001885</idno><idno type="wicri:Area/Main/Exploration">001885</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.</title><author><name sortKey="Funck Brentano, Christian" sort="Funck Brentano, Christian" uniqKey="Funck Brentano C" first="Christian" last="Funck-Brentano">Christian Funck-Brentano</name><affiliation wicri:level="3"><nlm:affiliation>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France. Electronic address: christian.funck-brentano@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Salem, Joe Elie" sort="Salem, Joe Elie" uniqKey="Salem J" first="Joe-Elie" last="Salem">Joe-Elie Salem</name><affiliation wicri:level="3"><nlm:affiliation>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Nguyen, Lee S" sort="Nguyen, Lee S" uniqKey="Nguyen L" first="Lee S" last="Nguyen">Lee S. Nguyen</name><affiliation wicri:level="3"><nlm:affiliation>Intensive Care Medicine department, Cochin University Hospital, AP-HP Centre, 75014 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Intensive Care Medicine department, Cochin University Hospital, AP-HP Centre, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Drici, Milou Daniel" sort="Drici, Milou Daniel" uniqKey="Drici M" first="Milou-Daniel" last="Drici">Milou-Daniel Drici</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pharmacology and Toxicology, PharmacoVigilance Centre, Hôpital de Cimiez, University of Nice Côte d'Azur Medical Centre, 06003, Nice, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Pharmacology and Toxicology, PharmacoVigilance Centre, Hôpital de Cimiez, University of Nice Côte d'Azur Medical Centre, 06003, Nice</wicri:regionArea><placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region><settlement type="city">Nice</settlement></placeName></affiliation></author><author><name sortKey="Roden, Dan M" sort="Roden, Dan M" uniqKey="Roden D" first="Dan M" last="Roden">Dan M. Roden</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN</wicri:regionArea><placeName><region type="state">Tennessee</region></placeName></affiliation></author></analytic><series><title level="j">Archives of cardiovascular diseases</title><idno type="eISSN">1875-2128</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Cardiovascular Diseases (MeSH)</term><term>Chloroquine (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>SARS-CoV-2 (MeSH)</term><term>Torsades de Pointes (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Azithromycine (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Chloroquine (MeSH)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Maladies cardiovasculaires (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term><term>Torsades de pointes (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Azithromycin</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Cardiovascular Diseases</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>SARS-CoV-2</term><term>Torsades de Pointes</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Azithromycine</term><term>Betacoronavirus</term><term>Chloroquine</term><term>Humains</term><term>Hydroxychloroquine</term><term>Maladies cardiovasculaires</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Torsades de pointes</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32331979</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-2128</ISSN><JournalIssue CitedMedium="Internet"><Volume>113</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>05</Month></PubDate></JournalIssue><Title>Archives of cardiovascular diseases</Title><ISOAbbreviation>Arch Cardiovasc Dis</ISOAbbreviation></Journal><ArticleTitle>Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.</ArticleTitle><Pagination><MedlinePgn>367-368</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1875-2136(20)30092-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.acvd.2020.04.001</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Funck-Brentano</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France. Electronic address: christian.funck-brentano@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Joe-Elie</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, INSERM, CIC Paris-Est (CIC-1901), Department of Pharmacology, 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Lee S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Intensive Care Medicine department, Cochin University Hospital, AP-HP Centre, 75014 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drici</LastName><ForeName>Milou-Daniel</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, PharmacoVigilance Centre, Hôpital de Cimiez, University of Nice Côte d'Azur Medical Centre, 06003, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roden</LastName><ForeName>Dan M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Arch Cardiovasc Dis</MedlineTA><NlmUniqueID>101465655</NlmUniqueID><ISSNLinking>1875-2128</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Arch Cardiovasc Dis. 2020 Apr;113(4):225-226</RefSource><PMID Version="1">32245656</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016171" MajorTopicYN="Y">Torsades de Pointes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Azithromycin</Keyword><Keyword MajorTopicYN="Y">Azithromycine</Keyword><Keyword MajorTopicYN="Y">Chloroquine</Keyword><Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword><Keyword MajorTopicYN="Y">Long QT syndrome</Keyword><Keyword MajorTopicYN="Y">Syndrome du QT long</Keyword><Keyword MajorTopicYN="Y">Torsade de Pointes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32331979</ArticleId><ArticleId IdType="pii">S1875-2136(20)30092-9</ArticleId><ArticleId IdType="doi">10.1016/j.acvd.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7158843</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2018 Dec 6;13(12):e0208321</Citation><ArticleIdList><ArticleId IdType="pubmed">30521586</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Toxicol (Phila). 2006;44(2):173-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16615675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Cardiovasc Dis. 2020 Apr;113(4):225-226</Citation><ArticleIdList><ArticleId IdType="pubmed">32245656</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Toxicol. 2015 Jul;35(7):799-805</Citation><ArticleIdList><ArticleId IdType="pubmed">25348819</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2012 Jun;56(6):3261-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22391528</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2019 Apr;105(4):943-953</Citation><ArticleIdList><ArticleId IdType="pubmed">30447156</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Arrhythm Electrophysiol. 2017 Apr;10(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">28408648</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>États-Unis</li></country><region><li>Provence-Alpes-Côte d'Azur</li><li>Tennessee</li><li>Île-de-France</li></region><settlement><li>Nice</li><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Funck Brentano, Christian" sort="Funck Brentano, Christian" uniqKey="Funck Brentano C" first="Christian" last="Funck-Brentano">Christian Funck-Brentano</name></region><name sortKey="Drici, Milou Daniel" sort="Drici, Milou Daniel" uniqKey="Drici M" first="Milou-Daniel" last="Drici">Milou-Daniel Drici</name><name sortKey="Nguyen, Lee S" sort="Nguyen, Lee S" uniqKey="Nguyen L" first="Lee S" last="Nguyen">Lee S. Nguyen</name><name sortKey="Salem, Joe Elie" sort="Salem, Joe Elie" uniqKey="Salem J" first="Joe-Elie" last="Salem">Joe-Elie Salem</name></country><country name="États-Unis"><region name="Tennessee"><name sortKey="Roden, Dan M" sort="Roden, Dan M" uniqKey="Roden D" first="Dan M" last="Roden">Dan M. Roden</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D27 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D27 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32331979
|texte= Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32331979" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |